Healthcare Investing: Obesity and Biotech Trends

This chapter examines the growth of healthcare investing, particularly in the obesity market and emerging drug therapies from leading companies. It also discusses recent trends in mergers and acquisitions within the biotech sector, driven by the need for innovative solutions amidst patent expirations. The chapter highlights investment opportunities while addressing the inherent risks associated with biotech ventures.